Skip to main content

What the FDA labels say about taking them together

Digoxin and epoprostenol

Digoxin's FDA label of December 5, 2024 names epoprostenol in its drug interactions section, and epoprostenol's label names digoxin too. The digoxin label: “Alprazolam, azithromycin, cyclosporine, diclofenac, diphenoxylate, epoprostenol, esomeprazole, ibuprofen, ketoconazole, lansoprazole, metformin, omeprazole; …”

Check it at the source: the digoxin FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.); the epoprostenol FDA label on DailyMed (effective November 28, 2022, Actelion Pharmaceuticals US, Inc.).

What does the digoxin label say about epoprostenol?

Digoxin label, drug interactions

Alprazolam, azithromycin, cyclosporine, diclofenac, diphenoxylate, epoprostenol, esomeprazole, ibuprofen, ketoconazole, lansoprazole, metformin, omeprazole; Measure serum digoxin concentrations before initiating concomitant drugs. Continue monitoring and reduce digoxin dose as necessary.

Source: FDA drug label (LANOXIN), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set d91e3646-4c63-4512-ab22-db39c085c4dc), via openFDA; the full label on DailyMed

What does the epoprostenol label say about digoxin?

Epoprostenol label, drug interactions

In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with epoprostenol was initiated, apparent oral clearance values for furosemide (n=23) and digoxin (n=30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.

Source: FDA drug label (Veletri), Actelion Pharmaceuticals US, Inc., effective November 28, 2022 (SPL set df502787-46ec-4dd1-a2c0-be90f6d95a5d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Digoxin generic labelers
3Epoprostenol generic labelers
DigoxinEpoprostenol
Labeled forHeart failure, Atrial fibrillationPulmonary arterial hypertension
Boxed warningNoNo
Pharmacy cost (NADAC)$0.133 per tablet 125 mcg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?